Antabio CEO Says M&A Is His ‘Exit Strategy’
‘Broken’ AMR Model Leaves Antibiotics Maker No Other Choice
Antibiotics specialist Antabio aims to get enough funding to advance its pipeline far enough to become a takeover target.
Antibiotics specialist Antabio aims to get enough funding to advance its pipeline far enough to become a takeover target.